143180EGP
- Active ingredient
- acalabrutinib
- Strength
- 100mg
- Form
- capsule
- Manufacturer
- astrazeneca > astrazeneca scientific office
- Route
- oral.solid
Uses
Bruton tyrosine kinase inhibitor used in certain B-cell malignancies including chronic lymphocytic leukemia and mantle cell lymphoma.
Do not use if
No absolute contraindications are universally established, except hypersensitivity to the product.
Side effects
Headache, diarrhea, fatigue, infections, bruising, and bleeding may occur.
Warnings
Monitor for bleeding, infections, cytopenias, and cardiac rhythm abnormalities.
How it works
Selectively inhibits Bruton tyrosine kinase, reducing malignant B-cell signaling and survival.
Storage
Store at room temperature in the original container.
